n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide has been researched along with thiostrepton in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmed, M; Al-Assiri, M; Al-Dayel, F; Al-Kuraya, KS; Al-Sanea, N; Beg, S; Hussain, AR; Siraj, AK; Uddin, S | 1 |
1 other study(ies) available for n-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide and thiostrepton
| Article | Year |
|---|---|
Co-targeting of Cyclooxygenase-2 and FoxM1 is a viable strategy in inducing anticancer effects in colorectal cancer cells.
Topics: Adult; Aged; Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Survival; Colorectal Neoplasms; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Synergism; Female; Forkhead Box Protein M1; Forkhead Transcription Factors; Gene Expression; Humans; Male; Mice; Middle Aged; Mitochondria; Neoplasm Grading; Neoplasm Staging; Nitrobenzenes; Signal Transduction; Sulfonamides; Thiostrepton; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |